111 ROE 2018-2024 | YI
Current and historical return on equity (ROE) values for 111 (YI) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| 111 ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2024-12-31 | $-0.01B | $-0.09B | 10.29% |
| 2024-09-30 | $-0.04B | $-0.09B | 41.86% |
| 2024-06-30 | $-0.05B | $-0.09B | 58.02% |
| 2024-03-31 | $-0.05B | $-0.08B | 70.90% |
| 2023-12-31 | $-0.06B | $-0.08B | 80.87% |
| 2023-09-30 | $-0.04B | $-0.07B | 65.08% |
| 2023-06-30 | $-0.04B | $-0.06B | 72.41% |
| 2023-03-31 | $-0.05B | $-0.06B | 88.89% |
| 2022-12-31 | $-0.06B | $-0.06B | 124.35% |
| 2022-09-30 | $-0.06B | $-0.05B | 162.03% |
| 2022-06-30 | $-0.09B | $-0.05B | 306.90% |
| 2022-03-31 | $-0.10B | $-0.04B | 869.57% |
| 2021-12-31 | $-0.11B | $-0.02B | -1135.14% |
| 2021-09-30 | $-0.11B | $-0.01B | -354.47% |
| 2021-06-30 | $-0.09B | $0.03B | -170.30% |
| 2021-03-31 | $-0.07B | $0.05B | -113.41% |
| 2020-12-31 | $-0.07B | $0.06B | -90.03% |
| 2020-09-30 | $-0.07B | $0.07B | -76.67% |
| 2020-06-30 | $-0.07B | $0.08B | -66.35% |
| 2020-03-31 | $-0.07B | $0.10B | -58.90% |
| 2019-12-31 | $-0.07B | $0.11B | -51.71% |
| 2019-09-30 | $-0.07B | $0.13B | -42.50% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.070B | $1.973B |
| 111, Inc. operates as a digital and mobile healthcare platform. The Company offers pharmacy distribution, medical consultancy, e-prescription and other services. 111, Inc. is headquartered in Shanghai, China. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.172B | 59.16 |
| Hims & Hers Health (HIMS) | United States | $12.418B | 139.02 |
| Tempus AI (TEM) | United States | $12.340B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.592B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.751B | 59.77 |
| Privia Health (PRVA) | United States | $2.761B | 190.75 |
| Hinge Health (HNGE) | United States | $2.719B | 0.00 |
| Enovis (ENOV) | United States | $1.822B | 10.27 |
| Schrodinger (SDGR) | United States | $1.572B | 0.00 |
| Phreesia (PHR) | United States | $1.547B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.468B | 0.00 |
| Azenta (AZTA) | United States | $1.401B | 65.30 |
| Omnicell (OMCL) | United States | $1.370B | 24.15 |
| 10x Genomics (TXG) | United States | $1.282B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.630B | 0.00 |
| Claritev (CTEV) | United States | $0.610B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.569B | 0.00 |
| Veradigm (MDRX) | United States | $0.487B | 0.00 |
| Talkspace (TALK) | United States | $0.477B | 140.50 |
| Standard BioTools (LAB) | United States | $0.399B | 0.00 |
| Outset Medical (OM) | United States | $0.354B | 0.00 |
| TruBridge (TBRG) | United States | $0.347B | 778.33 |
| Health Catalyst (HCAT) | United States | $0.264B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.257B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.191B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.149B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.138B | 0.00 |
| Pulmonx (LUNG) | United States | $0.122B | 0.00 |
| American Well (AMWL) | United States | $0.106B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.095B | 0.00 |
| CareCloud (CCLD) | United States | $0.088B | 3.44 |
| HeartBeam (BEAT) | United States | $0.051B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.048B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.033B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.032B | 0.00 |
| Zhongchao (ZCMD) | China | $0.029B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.022B | 0.00 |
| Precipio (PRPO) | United States | $0.016B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.012B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.009B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.001B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |